Press Release

Crown Laboratories Announces Adrianne Shapira has Joined its Board of Directors

February 20, 2025

Johnson City, TN, February 20, 2025 – Crown Laboratories, Inc. ("Crown"), is pleased to announce that Adrianne Shapira has joined its Board of Directors and will serve as Audit Committee Chair. Ms. Shapira has over 20 years of consumer/retail industry experience across finance and operating roles as well as private and public Board seats. This appointment reinforces Crown’s ability to compete, innovate, and lead in the skincare industry, making Ms. Shapira a key asset to Crown’s future success.

Ms. Shapira spent over 13 years at Goldman Sachs as Managing Director in Equity Research leading the Broadlines Retail universe. She was the Chief Financial Officer at David Yurman, a privately-held, luxury jewelry brand with a global omni-channel reach. Most recently, she was Managing Director at Eurazeo Brands, a mid-market private equity firm.

"We are thrilled to welcome Ms. Shapira to our Board of Directors,” said Jeff Bedard, Founder and CEO of Crown. “With her extensive experience spanning finance, retail, and consumer brands—combined with a proven track record of driving growth and innovation—Adrianne brings invaluable insight to Crown as we continue to expand our impact in skincare. Her leadership and strategic vision will be instrumental in shaping our future, and we look forward to the expertise she brings to our mission of delivering safe, effective solutions for lifelong healthy skin."

Said Ms. Shapira, “I am honored to join Crown Laboratories’ Board of Directors at such an exciting time for the company. Crown’s commitment to innovation, scientific excellence, and delivering high-quality skincare solutions aligns with my passion for building strong consumer brands. I look forward to collaborating with the leadership team and contributing to the company’s continued growth and success in the global skincare market."

About Crown Laboratories, Inc.

Crown, a privately held, fully integrated global skincare company, is committed to developing and providing a diverse portfolio of aesthetic, premium and therapeutic skincare products that improve the quality of life for its consumers throughout their skincare journey. An innovative company focused on skin science for life, Crown’s unyielding pursuit of delivering therapeutic excellence and enhanced patient outcomes is why it has become a leader in Dermatology and Aesthetics. Crown has been listed on the Inc. 5000 Fastest Growing Privately Held Companies List for eleven years and has expanded its distribution to over 60 countries. For more information, visit www.crownlaboratories.com.